Free Trial

Uniphar (UPR) Competitors

Uniphar logo
GBX 228.75 -3.25 (-1.40%)
As of 11:40 AM Eastern

UPR vs. UDG, HCM, GNS, CLIN, EMIS, INDV, VEC, ONT, CTH, and CRW

Should you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), HUTCHMED (HCM), Genus (GNS), Clinigen Group (CLIN), EMIS Group (EMIS), Indivior (INDV), Vectura Group (VEC), Oxford Nanopore Technologies (ONT), CareTech (CTH), and Craneware (CRW). These companies are all part of the "medical" sector.

Uniphar vs.

UDG Healthcare (LON:UDG) and Uniphar (LON:UPR) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, community ranking, dividends, analyst recommendations, institutional ownership, earnings and risk.

UDG Healthcare received 511 more outperform votes than Uniphar when rated by MarketBeat users. However, 100.00% of users gave Uniphar an outperform vote while only 74.68% of users gave UDG Healthcare an outperform vote.

CompanyUnderperformOutperform
UDG HealthcareOutperform Votes
519
74.68%
Underperform Votes
176
25.32%
UnipharOutperform Votes
8
100.00%
Underperform Votes
No Votes

45.3% of Uniphar shares are owned by institutional investors. 10.1% of Uniphar shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Uniphar has a net margin of 1.68% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.18% beat UDG Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
UDG HealthcareN/A N/A N/A
Uniphar 1.68%13.18%3.76%

Uniphar has a consensus target price of GBX 310, suggesting a potential upside of 35.52%. Given Uniphar's stronger consensus rating and higher possible upside, analysts clearly believe Uniphar is more favorable than UDG Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UDG Healthcare
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Uniphar
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

UDG Healthcare pays an annual dividend of GBX 0.17 per share. Uniphar pays an annual dividend of GBX 2 per share and has a dividend yield of 0.9%. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Uniphar pays out 13.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, UDG Healthcare's average media sentiment score of 0.00 equaled Uniphar'saverage media sentiment score.

Company Overall Sentiment
UDG Healthcare Neutral
Uniphar Neutral

Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UDG Healthcare£1.25B0.00N/A£25.40N/A
Uniphar£3.03B0.23£51.04M£14.3815.91

Summary

Uniphar beats UDG Healthcare on 11 of the 15 factors compared between the two stocks.

Remove Ads
Get Uniphar News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPR vs. The Competition

MetricUnipharMedical Distribution IndustryMedical SectorLON Exchange
Market Cap£712.06M£365.69M£5.54B£2.52B
Dividend Yield0.77%1.33%5.35%4.90%
P/E Ratio15.915.3823.25134.65
Price / Sales0.2312.10361.26261,054.86
Price / Cash9.979.9738.1627.90
Price / Book1.791.796.494.45
Net Income£51.04M£51.04M£3.21B£5.77B
7 Day Performance-1.40%-3.06%-6.42%-1.85%
1 Month Performance4.52%-2.72%-0.68%-2.65%
1 Year Performance3.04%-10.26%6.05%103.94%

Uniphar Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPR
Uniphar
N/AGBX 228.75
-1.4%
GBX 310
+35.5%
+2.7%£712.06M£3.03B15.913,000Gap Down
High Trading Volume
UDG
UDG Healthcare
N/AN/AN/AN/A£2.72B£1.25B42.489,000
HCM
HUTCHMED
N/AGBX 226
-3.0%
N/A-7.1%£2.45B£771.01M-57.681,760Gap Up
GNS
Genus
1.2806 of 5 stars
GBX 1,952
+0.4%
GBX 2,150
+10.1%
+4.4%£1.28B£666.67M161.80480News Coverage
High Trading Volume
CLIN
Clinigen Group
N/AN/AN/AN/A£1.23B£565.60M64.691,000
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
INDV
Indivior
2.3706 of 5 stars
GBX 752
-2.7%
GBX 1,650
+119.4%
-56.6%£1.17B£1.40B-623.521,000High Trading Volume
VEC
Vectura Group
N/AN/AN/AN/A£1.01B£190.60M8.209,200
ONT
Oxford Nanopore Technologies
2.4776 of 5 stars
GBX 102.90
-1.3%
GBX 227.50
+121.1%
-11.5%£976.57M£184.78M-5.541,281High Trading Volume
CTH
CareTech
N/AN/AN/AN/A£850.02M£495.40M10,714.2911,000
CRW
Craneware
1.8703 of 5 stars
GBX 1,847.50
-0.7%
GBX 2,800
+51.6%
-20.5%£793.81M£230.77M68.26734News Coverage
Negative News
Remove Ads

Related Companies and Tools


This page (LON:UPR) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners